ASX Penny Stocks To Watch In September 2026

As the Australian market navigates a challenging landscape with recent dips in the ASX200 and looming interest rate hikes, investors are keenly observing how these factors might influence their portfolios. Amid this climate of uncertainty, penny stocks—often smaller or newer companies—continue to capture attention for their potential to offer unique opportunities. Despite being an older term, penny stocks can still represent a compelling investment area when backed by solid financials and growth prospects, providing investors with the chance to uncover hidden value amidst broader market fluctuations.

Let's explore several standout options from the results in the screener.

Atturra (ASX:ATA)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Atturra Limited, with a market cap of A$153.03 million, offers advisory and information technology solutions across Australia, New Zealand, Singapore, and Hong Kong.

Operations: The company generates revenue from its Information Technology (IT) Solutions segment, amounting to A$351.81 million.

Market Cap: A$153.03M

Atturra Limited, with a market cap of A$153.03 million, recently faced challenges as it was dropped from the S&P/ASX All Ordinaries Index. Despite reporting sales of A$351.81 million for the year ending June 2026, Atturra posted a net loss of A$21.75 million, highlighting ongoing profitability issues. The company trades at 64.7% below its estimated fair value and has well-covered debt by operating cash flow but struggles with interest coverage due to negative earnings before interest and taxes (EBIT). Recent collaborations like those with Brickworks demonstrate potential in IT solutions despite current financial setbacks.

• Click here and access our complete financial health analysis report to understand the dynamics of Atturra.
• Examine Atturra's earnings growth report to understand how analysts expect it to perform.

Gold Hydrogen (ASX:GHY)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Gold Hydrogen Limited focuses on the discovery, exploration, and development of natural hydrogen and helium gas in Australia, with a market cap of A$98.35 million.

Operations: Gold Hydrogen Limited has not reported any revenue segments.

Market Cap: A$98.35M

Gold Hydrogen Limited, with a market cap of A$98.35 million, remains pre-revenue and faces significant financial hurdles. The company reported a net loss of A$2.48 million for the year ending June 2026, consistent with previous losses, and its auditor expressed doubts about its ability to continue as a going concern. Despite having no debt and short-term assets exceeding liabilities, Gold Hydrogen's cash runway is less than a year. Management inexperience presents additional challenges while stable weekly volatility offers some predictability for investors considering this speculative investment in natural hydrogen exploration.

• Navigate through the intricacies of Gold Hydrogen with our comprehensive balance sheet health report here.
• Gain insights into Gold Hydrogen's past trends and performance with our report on the company's historical track record.

Mastermyne Group (ASX:MYE)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Mastermyne Group Limited operates in Australia, offering mine operation, contracting, training, and related services within the mining and supporting industries, with a market cap of A$240.38 million.

Operations: The company generated A$237.75 million in revenue from its operations and services within the mining sector in Australia.

Market Cap: A$240.38M

Mastermyne Group Limited, with a market cap of A$240.38 million, reported revenue of A$237.75 million for the fiscal year ending June 2026. Despite its low net profit margin of 0.9%, the company's debt is well-covered by operating cash flow and it maintains more cash than total debt, indicating strong financial health. The recent appointment of experienced executive Gerhard Redelinghuys as a Non-Executive Director could bolster strategic direction as the company seeks acquisitions to enhance growth potential. However, challenges include negative earnings growth over the past year and high share price volatility compared to most Australian stocks.

• Click here to discover the nuances of Mastermyne Group with our detailed analytical financial health report.
• Explore historical data to track Mastermyne Group's performance over time in our past results report.

Taking Advantage

• Get an in-depth perspective on all 398 ASX Penny Stocks by using our screener here.
• Looking For Alternative Opportunities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com